Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Apr;7(4 Pt 1):1518-28.
doi: 10.1111/j.1743-6109.2009.01699.x. Epub 2010 Feb 5.

Erectogenic and neurotrophic effects of icariin, a purified extract of horny goat weed (Epimedium spp.) in vitro and in vivo

Affiliations

Erectogenic and neurotrophic effects of icariin, a purified extract of horny goat weed (Epimedium spp.) in vitro and in vivo

Alan W Shindel et al. J Sex Med. 2010 Apr.

Abstract

Introduction: Epimedium species (aka horny goat weed) have been utilized for the treatment of erectile dysfunction in Traditional Chinese Medicine for many years. Icariin (ICA) is the active moiety of Epimedium species.

Aim: To evaluate the penile hemodynamic and tissue effects of ICA in cavernous nerve injured rats. We also studied the in vitro effects of ICA on cultured pelvic ganglia.

Methods: Rats were subjected to cavernous nerve injury and subsequently treated for 4 weeks with daily gavage feedings of a placebo solution of normal saline and Dimethyl sulfoxide (DMSO) vs. ICA dissolved in DMSO at doses of 1, 5, and 10 mg/kg. A separate group underwent a single dose of ICA 10 mg/kg 2 hours prior to functional testing. Functional testing with cavernous nerve stimulation and real-time assessment of intracavernous pressure (ICP) was performed at 4 weeks. After functional testing, penile tissue was procured for immunohistochemistry and molecular studies. In separate experiments, pelvic ganglia were excised from healthy rats and cultured in the presence of ICA, sildenafil, or placebo culture media.

Main outcome measure: Ratio of ICP and area under the curve (AUC) to mean arterial pressure (MAP) during cavernous nerve stimulation of subject rodents. We also assayed tissue expression of neuronal nitric oxide synthase (nNOS), eNOS: endothelial nitric oxide synthase (eNOS), calponin, and apoptosis via immunohistochemistry and Western blot. Serum testosterone and luteinizing hormone (LH) were assayed using enzyme-linked immunosorbant assay (ELISA). Differential length of neurite outgrowth was assessed in cultured pelvic ganglia.

Results: Rats treated with low-dose ICA demonstrated significantly higher ICP/MAP and AUC/MAP ratios compared with control and single-dose ICA animals. Immunohistochemistry and Western blot were revealing of significantly greater positivity for nNOS and calponin in penile tissues of all rats treated with ICA. ICA led to significantly greater neurite length in cultured specimens of pelvic ganglia.

Conclusion: ICA may have neurotrophic effects in addition to known phosphodiesterase type 5 inhibiting effects.

PubMed Disclaimer

Figures

Figure 1
Figure 1
ICP/MAP assessment in cavernous nerve injured rats. (A) mean ICP/MAP ratio in all groups; (B) mean AUC/MAP ratio in all groups (*P < 0.01 vs. control group and single dose group, †P < 0.05 vs. control group and single dose group). AUC = area under the curve; ICP = intracavernous pressure; MAP = mean arterial pressure.
Figure 2
Figure 2
nNOS Immunohistochemistry. (A) representative images from rats in the sham, control, ICA 1 mg/kg, and ICA 10 mg/kg groups (arrows indicate small positive staining fibers); (B) mean nNOS positivity in the sham, control, ICA 1 mg/kg, and ICA 10 mg/kg groups (**P < 0.05 vs. all other groups, *P < 0.05 and #P < 0.08 vs. control group). hpf = high-power fields; ICA = icariin.
Figure 3
Figure 3
Western blot for nNOS, eNOS, and calponin. (A) Western blot normalized to alpha-actin; (B) mean nNOS positivity; (C) mean eNOS positivity; (D) mean calponin positivity (*P < 0.05 vs. control and single dose animals).
Figure 4
Figure 4
eNOS Immunohistochemistry. (A) representative images from rats in the sham, control, ICA 1 mg/kg, and ICA 10 mg/kg groups; (B) mean eNOS positivity in the sham, control, ICA 1 mg/kg, and ICA 10 mg/kg groups (*P < 0.05 relative to control animals). ICA = icariin.
Figure 5
Figure 5
Calponin Immunohistochemistry. (A) Representative images from rats in the sham, control, ICA 1 mg/kg, and ICA 10 mg/kg groups. (B) mean calponin positivity in the sham, control, ICA 1 mg/kg, and ICA 10 mg/kg groups (*P < 0.05 relative to control animals). ICA = icariin.
Figure 6
Figure 6
Gonadotropin and testosterone levels. (A) Serum testosterone level (*P < 0.05 relative to ICA 10 mg/kg animals); (B) serum LH level. ICA = icariin.
Figure 7
Figure 7
Neurite outgrowth in cell culture under various treatment conditions. (A) Representative images from cultured major pelvic ganglia in the control (top two panels), ICA (left column) and sildenafil (right column). Arrows and numbers indicate length and position of longest neurite; (B) mean neurite length in the various treatment groups (*P < 0.05 vs. control, **P < 0.05 vs. control and all sildenafil groups). ICA = icariin.

Similar articles

Cited by

References

    1. Xin ZC, Kim E, Tian ZJ, Ling GT, Guo YL. Icariin on relaxation effect of corpus cavernosum smooth muscle. Chin Sci Bull. 2001;46:1186–90.
    1. Ning H, Xin ZC, Lin G, Banie L, Lue TF, Lin CS. Effects of icariin on phosphodiesterase-5 activity in vitro and cyclic guanosine monophosphate level in cavernous smooth muscle cells. Urology. 2006;68:1350–4. - PubMed
    1. Dell'Agli M, Galli GV, Dal Cero E, Belluti F, Matera R, Zironi E, Pagliuca G, Bosisio E. Potent inhibition of human phosphodiesterase-5 by icariin derivatives. J Nat Prod. 2008;71:1513–7. - PubMed
    1. Zhang ZB, Yang QT. The testosterone mimetic properties of icariin. Asian J Androl. 2006;8:601–5. - PubMed
    1. Wang YK, Huang ZQ. Protective effects of icariin on human umbilical vein endothelial cell injury induced by H2O2 in vitro. Pharmacol Res. 2005;52:174–82. - PubMed

Publication types

MeSH terms